TOLERANCE INDUCTION BY MEGADOSE HEMATOPOIETIC TRANSPLANTS - DONOR-TYPE HUMAN CD34 STEM-CELLS INDUCE POTENT SPECIFIC REDUCTION OF HOST ANTIDONOR CYTOTOXIC T-LYMPHOCYTE PRECURSORS IN MIXED LYMPHOCYTE CULTURE
N. Rachamim et al., TOLERANCE INDUCTION BY MEGADOSE HEMATOPOIETIC TRANSPLANTS - DONOR-TYPE HUMAN CD34 STEM-CELLS INDUCE POTENT SPECIFIC REDUCTION OF HOST ANTIDONOR CYTOTOXIC T-LYMPHOCYTE PRECURSORS IN MIXED LYMPHOCYTE CULTURE, Transplantation, 65(10), 1998, pp. 1386-1393
Background Recently, the use of megadoses of CD34(+) hematopoietic pro
genitors has been reported to abrogate resistance to engraftment, thus
overcoming major histocompatibility barriers in bone marrow transplan
tation in leukemia patients. Methods. The ability of human CD34(+) cel
ls to possess potent tolerizing activity was studied by limiting dilut
ion analysis of cytotoxic T lymphocyte (CTL) precursors (CTL-p) in hum
an peripheral blood lymphocytes after addition of purified CD34(+) cel
ls, Results, The addition of purified human CD34(+) cells to primary m
ixed lymphocyte culture led to a marked reduction of antiallogeneic CT
L-p frequency against stimulator cells of the same origin, compared wi
th the response against cells of third-party origin. The CD34(+) cells
caused a marked inhibition of the CTL activity, when added at an equa
l number with the responder T cells, and they were still present after
the mixed lymphocyte culture, which suggests that no significant kill
ing of CD34(+) cells had occurred. The tolerizing activity is abrogate
d by irradiation and requires cell contact. This pattern of tolerizati
on most closely resembles what has been ascribed to veto cells in othe
r systems. Phenotypic analysis of the purified CD34(+) cells showed th
at they express MHC class I and class II antigens, but do not express
costimulatory molecules of the B7 family, Conclusions. It is possible,
that CD34(+) cells in the megadose transplants-perhaps by their inabi
lity to provide costimulatory molecules-are actively reducing the freq
uency of CTL-p directed against their antigens, and thereby help to ov
ercome allogeneic rejection, and enhance their own engraftment.